Virtu Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$61K Buy
+32,497
New +$72.5K ﹤0.01% 1234
2026
Q1
– Sell
-36,468
Closed -$42K – 2024
2025
Q4
$42K Buy
+36,468
New +$50.1K ﹤0.01% 1328
2025
Q3
– Sell
-146,805
Closed -$139K – 1826
2025
Q2
$139K Buy
+146,805
New +$95.1K 0.01% 986
2025
Q1
– Sell
-88,982
Closed -$66K – 1743
2024
Q4
$66K Buy
+88,982
New +$107K ﹤0.01% 1109
2024
Q2
– Sell
-43,591
Closed -$105K – 1639
2024
Q1
$105K Buy
+43,591
New +$93.6K 0.01% 918
2023
Q3
– Sell
-19,948
Closed -$46K – 1637
2023
Q2
$46K Sell
19,948
-1,781
-8% -$4.73K ﹤0.01% 1148
2023
Q1
$53K Buy
+21,729
New +$49.8K 0.01% 1084
2022
Q4
– Sell
-13,458
Closed -$32K – 1936
2022
Q3
$32K Buy
+13,458
New +$37.2K ﹤0.01% 1301
2020
Q3
– Sell
-69,282
Closed -$138K – 1324
2020
Q2
$138K Buy
+69,282
New +$136K 0.02% 806
2019
Q2
– Sell
-35,164
Closed -$196K – 1684
2019
Q1
$196K Buy
+35,164
New +$214K 0.01% 1017
2017
Q4
– Sell
-11,993
Closed -$147K – 2726
2017
Q3
$147K Buy
+11,993
New +$177K 0.01% 1970
2014
Q2
– Sell
-2,398
Closed -$29K – 397
2014
Q1
$29K Buy
+2,398
New +$30.6K ﹤0.01% 384

Other funds holding LXRX

Virtu Financial's LXRX Position: Q3 2026 in Review

Virtu Financial opened a new position in Lexicon Pharmaceuticals (LXRX) in Q3 2026: 32,497 shares worth $61K. The stake represents ﹤0.01% of the portfolio and ranks #1234 among its holdings. This is a return to the name: Virtu Financial previously reported a position in LXRX as recently as Q4 2025.

Virtu Financial first reported a position in LXRX in Q1 2014 and has held it in 12 quarters since. The position peaked at $196K in Q1 2019. 157 funds tracked by Wall St. Rank hold LXRX as of Q3 2026.

  • Virtu Financial held 32,497 shares of Lexicon Pharmaceuticals worth $61K as of Q3 2026.
  • Lexicon Pharmaceuticals was a new Virtu Financial position in Q3 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q3 2026, its #1234 holding.
  • Virtu Financial first reported a position in Lexicon Pharmaceuticals in Q1 2014 and has held it in 12 quarters since.
  • Virtu Financial's Lexicon Pharmaceuticals position peaked at $196K in Q1 2019.
  • 157 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2026.

Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.